Darbepoetin Alfa Effectively Treats Anemia in Patients with Chronic Kidney Disease with de novo Every-Other-Week Administration

Publisher： Karger

E-ISSN： 1421-9670|24|4|453-460

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.24, Iss.4, 2004-09, pp. : 453-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Anemia with Darbepoetin Alfa Administered de novo Once Every Other Week in Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 23, Iss. 2, 2003-01 ,pp. : 106-111

Karger

Access to resources Recommend Favorite

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-01 ,pp. : 187-199

Karger

Access to resources Recommend Favorite

Conversion of Darbepoetin to Low Doses of CERA Maintains Hemoglobin Levels in Non-Dialysis Chronic Kidney Disease Patients

By  

Blood Purification, Vol. 30, Iss. 3, 2010-10 ,pp. : 186-194

Karger

Access to resources Recommend Favorite

Impact of Chronic Kidney Disease and Anemia on Physical Function in Patients with Chronic Heart Failure

By  

Cardiorenal Medicine, Vol. 4, Iss. 2, 2014-04 ,pp. : 73-81

Karger

Access to resources Recommend Favorite

Anemia in Chronic Kidney Disease and Congestive Heart Failure

By  

Blood Purification, Vol. 21, Iss. 1, 2003-01 ,pp. : 124-130

Karger

Access to resources Recommend Favorite